Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 04, 2020

SELL
$126.05 - $152.76 $365,545 - $443,004
-2,900 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$125.07 - $143.67 $73,040 - $83,903
-584 Reduced 16.76%
2,900 $384,000
Q2 2019

Aug 06, 2019

BUY
$123.4 - $148.55 $429,925 - $517,548
3,484 New
3,484 $494,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.